Advertisements


VistaGen Therapeutics issued two key U.S. patents covering AV-101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

VistaGen Therapeutics Reports Fiscal Year 2018 Financial Results and Provides Year-to-Date Highlights

AV-101, VistaGen's Oral NMDA Receptor Modulator, Granted FDA Fast-Track Designation for Major Depressive Disorder Key AV-101 Patents Issued .....»»

Category: earningsSource: benzingaJun 26th, 2018

uniQure issued new patents covering methods of treating coagulopathies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2018

VistaGen Therapeutics receives notices of allowance from IP Australia, JPO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

VistaGen Therapeutics acquires license, worldwide rights to PH10 from Pherin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

Microsoft joins OIN with portfolio of 60,000 issued patents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Mid-Afternoon Market Update: Crude Oil Rises 1.75%; VistaGen Therapeutics Shares Spike Higher

Toward the end of trading Wednesday, the Dow traded up 0.60 percent to 26,935.16 while the NASDAQ climbed 0.66 percent to 8,052.12. The S&P also rose, gaining 0.47 percent to 2,937.25. read more.....»»

Category: blogSource: benzingaOct 3rd, 2018

VistaGen Therapeutics announces FDA fast track designation for AV-101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 3rd, 2018

VistaGen shares surge 13% after FDA grants fast track status to non-opioid pain treatment

VistaGen Therapeutics Inc.'s stock surged 13% in premarket trade Wednesday, after the company said it h.....»»

Category: topSource: marketwatchOct 3rd, 2018

VistaGen Therapeutics, Pherin Pharmaceuticals announce license agreement

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

The Most Innovative Company By Patents: Old Tech Is #1

The most innovative companies, states and countries in the world In June, the United States Patent and Trademark Office issued its 10 mil.....»»

Category: blogSource: valuewalkSep 12th, 2018

Acorda"s stock plunges after disappointing ruling regarding patents for MS treatment

Shares of Acorda Therapeutics Inc. plunged 21% toward an 8-month low in midday trade Monday, after a disappointing ruling a federal appeals court on patents pertaining to its multiple sclerosis treatment, Ampy.....»»

Category: topSource: marketwatchSep 10th, 2018

Acorda"s stock plunges after disappointing ruling regarding patents for Parkinson"s treatment

Shares of Acorda Therapeutics Inc. plunged 21% toward an 8-month low in midday trade Monday, after a disappointing ruling a federal appeals court on patents pertaining to its Parkinson's disease treatment, Ampy.....»»

Category: topSource: marketwatchSep 10th, 2018

Protagonist Therapeutics expands IP portfolio with three new U.S. patents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 6th, 2018

Pope"s Accuser Sparks Deep Divisions Within Church

The Vatican hasn’t issued a response a week after a former Vatican diplomat accused Pope Francis of covering up sexual misconduct, but former officials are disputing some his claims—while other churchmen have vouched for his integrity......»»

Category: topSource: wsjSep 4th, 2018

Intellia Therapeutics (NTLA) Educational Briefing On Interference Proceedings Relating To CRISPR/Cas9 Genome Editing Technology Patents - Slideshow

Intellia Therapeutics (NTLA) Educational Briefing On Interference Proceedings Relating To CRISPR/Cas9 Genome Editing Technology Patents - Slideshow.....»»

Category: topSource: seekingalphaAug 29th, 2018

Fortinet announces milestone of over 500 issued patents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 22nd, 2018

BioTime acquires certain patents, patent applications from Escape Therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 16th, 2018

VistaGen Therapeutics, Baylor to collaborate on study for anti-suicidal effects

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 13th, 2018

Sarepta"s DMD Portfolio Solid, Sole Drug Dependence Concerns

Sarepta Therapeutics' (SRPT) DMD drug sales are rising and pipeline candidates are progressing well. However, dependence on a single product for near-term growth is a concern. On Jul 4, we issued a.....»»

Category: dealsSource: nytJul 5th, 2018

VistaGen Therapeutics initiated with a Buy at Maxim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 27th, 2018